US Stock MarketDetailed Quotes

VRNA Verona Pharma

Watchlist

12.010
-0.130-1.07%

Close Jun 6 16:00 ET

12.400
+0.390+3.25%

Post 19:53 ET

973.79MMarket Cap-15012P/E (TTM)

Verona Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-98.86%458K

458K

Operating revenue

--0

-98.86%458K

--458K

--0

Cost of revenue

346K

Gross profit

-99.72%112K

Operating expense

33.83%26.61M

0.36%66.47M

25.72%18.06M

27.84%16.62M

-21.19%11.9M

-16.32%19.89M

-32.20%66.23M

-38.85%14.37M

-54.69%13M

-38.90%15.1M

Selling and administrative expenses

113.10%20.43M

89.45%50.35M

79.89%14.97M

152.42%13.35M

125.10%12.44M

28.88%9.59M

-21.61%26.58M

44.57%8.32M

-51.39%5.29M

-30.80%5.53M

Research and development costs

-46.36%6.76M

-65.07%17.22M

-39.72%4.12M

-69.93%2.96M

-116.51%-2.47M

-28.45%12.61M

-37.94%49.28M

-69.89%6.84M

-56.39%9.84M

-27.14%14.98M

Other taxes

74.71%-585K

88.54%-1.1M

-29.90%-1.03M

114.53%309K

135.76%1.93M

-77.65%-2.31M

38.36%-9.63M

84.00%-796K

55.21%-2.13M

-41.01%-5.41M

Operating profit

-33.83%-26.61M

-0.53%-66.47M

-26.71%-18.06M

-27.84%-16.62M

21.19%-11.9M

16.32%-19.89M

-14.62%-66.12M

39.33%-14.25M

-214.99%-13M

38.90%-15.1M

Net non-operating interest income expense

-24.83%1.79M

365.39%10.7M

63.54%2.67M

350.83%2.99M

3,497.30%2.66M

3,555.07%2.38M

805.52%2.3M

2,090.24%1.63M

908.54%663K

190.24%74K

Non-operating interest income

26.19%3.38M

352.36%12.76M

76.80%3.29M

335.17%3.39M

1,961.82%3.4M

17,746.67%2.68M

20,050.00%2.82M

61,966.67%1.86M

19,375.00%779K

5,400.00%165K

Non-operating interest expense

441.30%1.59M

294.82%2.06M

170.87%623K

245.69%401K

713.19%740K

248.81%293K

53.24%521K

170.59%230K

34.88%116K

7.06%91K

Other net income (expense)

-123.50%-219K

140.28%1.87M

-45.13%1.21M

68.81%-1.01M

127.80%740K

200.98%932K

-291.25%-4.63M

3,503.28%2.2M

-6,954.35%-3.25M

-196.76%-2.66M

Gain on sale of security

-123.50%-219K

148.89%1.87M

-59.97%1.21M

68.81%-1.01M

127.80%740K

200.98%932K

-257.60%-3.82M

4,839.34%3.01M

-6,954.35%-3.25M

-196.76%-2.66M

Special income (charges)

----

--0

----

---815K

----

-Less:Other special charges

----

--815K

----

Income before tax

-51.12%-25.04M

21.26%-53.9M

-36.09%-14.19M

6.03%-14.64M

51.96%-8.5M

33.06%-16.57M

-23.14%-68.45M

55.67%-10.42M

-239.41%-15.58M

19.76%-17.69M

Income tax

335.84%754K

87.35%474K

-289.29%-53K

-31.25%44K

292.41%310K

110.98%173K

1,505.56%253K

111.20%28K

-49.61%64K

216.00%79K

Net income

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

19.49%-17.77M

Net income continuous Operations

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

19.49%-17.77M

Minority interest income

Net income attributable to the parent company

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

19.49%-17.77M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-54.06%-25.79M

20.86%-54.37M

-35.22%-14.13M

6.14%-14.69M

50.43%-8.81M

32.59%-16.74M

-23.63%-68.7M

55.07%-10.45M

-241.59%-15.65M

19.49%-17.77M

Basic earnings per share

-33.33%-0.32

30.77%-0.72

-200.00%-0.24

33.33%-0.16

75.00%-0.08

40.00%-0.24

-8.33%-1.04

80.00%-0.08

-250.00%-0.24

20.00%-0.32

Diluted earnings per share

-33.33%-0.32

30.77%-0.72

-200.00%-0.24

33.33%-0.16

75.00%-0.08

40.00%-0.24

-8.33%-1.04

80.00%-0.08

-250.00%-0.24

20.00%-0.32

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	-98.86%458K	458K	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	-98.86%458K	--458K	--0	--0
Cost of revenue		0					346K
Gross profit		0					-99.72%112K
Operating expense	33.83%26.61M	0.36%66.47M	25.72%18.06M	27.84%16.62M	-21.19%11.9M	-16.32%19.89M	-32.20%66.23M	-38.85%14.37M	-54.69%13M	-38.90%15.1M
Selling and administrative expenses	113.10%20.43M	89.45%50.35M	79.89%14.97M	152.42%13.35M	125.10%12.44M	28.88%9.59M	-21.61%26.58M	44.57%8.32M	-51.39%5.29M	-30.80%5.53M
Research and development costs	-46.36%6.76M	-65.07%17.22M	-39.72%4.12M	-69.93%2.96M	-116.51%-2.47M	-28.45%12.61M	-37.94%49.28M	-69.89%6.84M	-56.39%9.84M	-27.14%14.98M
Other taxes	74.71%-585K	88.54%-1.1M	-29.90%-1.03M	114.53%309K	135.76%1.93M	-77.65%-2.31M	38.36%-9.63M	84.00%-796K	55.21%-2.13M	-41.01%-5.41M
Operating profit	-33.83%-26.61M	-0.53%-66.47M	-26.71%-18.06M	-27.84%-16.62M	21.19%-11.9M	16.32%-19.89M	-14.62%-66.12M	39.33%-14.25M	-214.99%-13M	38.90%-15.1M
Net non-operating interest income expense	-24.83%1.79M	365.39%10.7M	63.54%2.67M	350.83%2.99M	3,497.30%2.66M	3,555.07%2.38M	805.52%2.3M	2,090.24%1.63M	908.54%663K	190.24%74K
Non-operating interest income	26.19%3.38M	352.36%12.76M	76.80%3.29M	335.17%3.39M	1,961.82%3.4M	17,746.67%2.68M	20,050.00%2.82M	61,966.67%1.86M	19,375.00%779K	5,400.00%165K
Non-operating interest expense	441.30%1.59M	294.82%2.06M	170.87%623K	245.69%401K	713.19%740K	248.81%293K	53.24%521K	170.59%230K	34.88%116K	7.06%91K
Other net income (expense)	-123.50%-219K	140.28%1.87M	-45.13%1.21M	68.81%-1.01M	127.80%740K	200.98%932K	-291.25%-4.63M	3,503.28%2.2M	-6,954.35%-3.25M	-196.76%-2.66M
Gain on sale of security	-123.50%-219K	148.89%1.87M	-59.97%1.21M	68.81%-1.01M	127.80%740K	200.98%932K	-257.60%-3.82M	4,839.34%3.01M	-6,954.35%-3.25M	-196.76%-2.66M
Special income (charges)	----	--0	----	----	----	----	---815K	----	----	----
-Less:Other special charges	----	----	----	----	----	----	--815K	----	----	----
Income before tax	-51.12%-25.04M	21.26%-53.9M	-36.09%-14.19M	6.03%-14.64M	51.96%-8.5M	33.06%-16.57M	-23.14%-68.45M	55.67%-10.42M	-239.41%-15.58M	19.76%-17.69M
Income tax	335.84%754K	87.35%474K	-289.29%-53K	-31.25%44K	292.41%310K	110.98%173K	1,505.56%253K	111.20%28K	-49.61%64K	216.00%79K
Net income	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M	19.49%-17.77M
Net income continuous Operations	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M	19.49%-17.77M
Minority interest income
Net income attributable to the parent company	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M	19.49%-17.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-54.06%-25.79M	20.86%-54.37M	-35.22%-14.13M	6.14%-14.69M	50.43%-8.81M	32.59%-16.74M	-23.63%-68.7M	55.07%-10.45M	-241.59%-15.65M	19.49%-17.77M
Basic earnings per share	-33.33%-0.32	30.77%-0.72	-200.00%-0.24	33.33%-0.16	75.00%-0.08	40.00%-0.24	-8.33%-1.04	80.00%-0.08	-250.00%-0.24	20.00%-0.32
Diluted earnings per share	-33.33%-0.32	30.77%-0.72	-200.00%-0.24	33.33%-0.16	75.00%-0.08	40.00%-0.24	-8.33%-1.04	80.00%-0.08	-250.00%-0.24	20.00%-0.32
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall